| Trial ID: | L6549 |
| Source ID: | NCT00843388
|
| Associated Drug: |
Spironolacton (Hexalacton(R))
|
| Title: |
A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Nephropathy|Blood Pressure
|
| Interventions: |
DRUG: Spironolacton (hexalacton(R))|DRUG: placebo tablet
|
| Outcome Measures: |
Primary: albuminuria, expected decrease, 60 days | Secondary: GFR, 60 days|ambulatory blood pressure, 60 days|plasma renin, angiotensin, aldosteron, 60 days
|
| Sponsor/Collaborators: |
Sponsor: Steno Diabetes Center Copenhagen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
2010-03
|
| Results First Posted: |
|
| Last Update Posted: |
2009-02-13
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00843388
|
